116 biostatistics jobs at 63 companies in Massachusetts
3mo
Save
Mark Applied
Hide
3mo
Director, Biostatistics
Burlington, Massachusetts, United States
$195k-$245k/yrHybridFull Time
MapLight TherapeuticsNASDAQ: MPLT: Develops targeted drug therapies for central nervous system disorders.
7+ YOEPhD or Master’s with extensive biostatistics experience in clinical trials; regulatory knowledge; proficient in SAS/R; CRO oversight; CNS endpoints.
Sarepta TherapeuticsNASDAQ: SRPT: Develops precision genetic medicines for rare diseases.
9+ YOEPh.D. strongly preferred or Master’s with extensive biostatistics/clinical trials experience; expert in SAS and R; knowledge of FDA/EMA guidelines; leadership in biometrics; ability to mentor.
Beeline Medicines: A clinical-stage biotechnology developing precision therapies for autoimmune and inflammatory diseases.
12+ YOEPhD in biostatistics or related, 12+ years biostatistics experience in pharma/biotech/CRO, regulatory submission experience, expertise in clinical trial design and CDISC standards, proficiency in SAS or R.
Vertex PharmaceuticalsNASDAQ: VRTX: Develops and sells prescription drugs for serious genetic diseases.
10+ YOEPh.D. or master's degree in Statistics or Biostatistics; typically 10 years of experience with a Ph.D. or 13 years with a master's degree; expertise in SAS, R, complex statistical methods, drug development, and regulatory interactions.
Bristol Myers SquibbNew York Stock Exchange: BMY: Develops and distributes innovative medicines for serious diseases.
3+ YOEPhD+3yrs or MS+5yrs in statistics/biostatistics, proficiency in SAS,R,Python, experience with clinical trials, regulatory knowledge, strong communication and leadership skills.
3+ YOEPhD (3+ years) or MS (5+ years) in statistics/biostatistics, clinical trials experience, proficiency with SAS,R,Python, strong communication and regulatory understanding.
Bicycle TherapeuticsNASDAQ: BCYC: Developing synthetic peptide medicines for oncology and other diseases.
Senior biostatistics leader with deep oncology clinical trials experience, people management, advanced statistical methods knowledge, regulatory (GCP) experience, and proficiency with R and SAS.
Dyne TherapeuticsNASDAQ: DYN: Developing therapeutics for genetically driven neuromuscular diseases.
12+ YOEPh.D. or Masters in statistics/biostatistics,12+ years pharma/biotech experience,expertise in clinical trial design,CDISC (SDTM/ADaM),advanced SAS (R a plus),regulatory submission experience.
Cambridge or United States or Alaska or Arizona or Hawaii or Michigan or Tennessee
$221k-$249k/yrRemoteFull Time
Amylyx PharmaceuticalsNASDAQ: AMLX: Develops treatments for neurodegenerative diseases and endocrine conditions.
10+ YOEPhD (10+ years) or MSc (14+ years) in statistics/biostatistics/math; proficiency with SAS or R and CDISC; experience designing late-phase clinical trials, regulatory interactions, leadership and communication skills.
Alnylam PharmaceuticalsNASDAQ: ALNY: Develops RNAi therapeutics to treat rare and common diseases.
7+ YOEPhD in biostatistics/statistics/mathematics/related and 7+ years experience; expertise in SAS,R,EAST,CDISC; Bayesian and dose-response modeling; interim analysis; Phase 3 development; ICH GCP; adaptive trials; regulatory interactions.
Remix Therapeutics: Develops small molecule therapies to reprogram RNA processing.
15+ YOE5+ MgmtLead biostatistics strategy and team for oncology programs; design and oversight of clinical trials; regulatory readiness and vendor management.
AlkermesNASDAQ: ALKS: Develops medicines for psychiatric and neurological disorders.
16+ YOEPh.D. in Statistics/Biostatistics, 16+ years clinical research and drug development experience; neuroscience and regulatory experience preferred; strong analytical and communication skills.
Zenas BioPharmaNASDAQ: ZBIO: Develops transformative therapies for patients with autoimmune diseases.
10+ YOEPhD in statistics/biostatistics, 10+ years clinical research/drug development experience, SAS proficiency, CRO oversight, regulatory submission experience, leadership and statistical programming skills.
PepGenNASDAQ: PEPG: Developing oligonucleotide therapies for neuromuscular and neurological diseases.
8+ YOEMS in biostatistics, statistics, or related field and 8+ years in pharmaceutical drug development. Hands-on SAS and R clinical-trial programming, regulatory submissions, and CRO/vendor management experience required.
SAS, R, Tables, Listings, Figures (TLFs), Study Data Tabulation Model (SDTM), Analysis Data Model (ADaM)
Rapport TherapeuticsNASDAQ: RAPP: Developing precision medicines for neurological and psychiatric disorders.
3+ YOEPhD with 3+ or MS with 6+ years for Senior Manager; PhD with 6+ or MS with 9+ years for Associate Director. Requires biostatistics, clinical trial, SAS or R, CDISC, and regulatory expertise.
Tango TherapeuticsNasdaq Capital Market: TNGX: Develops precision cancer medicines using synthetic lethality principles.
10+ YOEPhD in statistics or related discipline, or MS with relevant experience; 10+ years in pharmaceutical or biotech industry; oncology and clinical trial experience; SAS and R proficiency; regulatory submission and data standards expertise.
15+ YOEDoctorate in statistics/biostatistics/mathematics, 15+ years pharma/biotech experience with senior leadership, deep GCP/regulatory knowledge, advanced analytics/AI interest, international travel ~20%, relocation assistance offered.
Cogent BiosciencesNASDAQ: COGT: Develops precision therapies for genetically defined diseases
8+ YOEPhD in Biostatistics (8+ yrs) or MS (10+ yrs); lead statistician experience in oncology preferred; experience supporting NDA/BLA submissions; proficiency in SAS, EAST, nQuery or PASS; experience with CDISC (SDTM/ADaM/CDASH).